ArticlePloS one2019

Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practice.

Dong Kyu Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.